Can I sell supplements on Stripe or Shopify Payments?

Sometimes, but not safely at scale. Stripe and Shopify Payments both restrict supplement categories they deem high-risk, and enforcement is inconsistent: brands run for months and then get terminated with funds held, often right as ad spend peaks. If you are past roughly $50K per month, move core volume to a dedicated high-risk merchant account and keep the aggregator, if at all, as a small secondary rail.

What chargeback rate will get my supplement MID shut down?

Visa's VAMP program, which replaced the old VDMP and VFMP programs in 2025, and Mastercard's ECM program are the formal thresholds, but your acquirer will act well before the card brands do. In practice most high-risk acquirers start conversations around 0.9 to 1 percent and terminate or reserve heavily beyond that. Continuity nutra offers need alerts and pre-rebill notifications to stay under those lines.

Do I need to change my funnel to get approved?

Usually yes, at least at the margins. Underwriters will reject funnels with disease claims, fake countdown scarcity, undisclosed continuity terms, or checkout pages where the rebill terms are not adjacent to the buy button. Cleaning those up before applying is faster than arguing after a decline, and it also lowers the disputes that would threaten the account later.

High-risk vertical

Nutraceuticals & Supplements: payment processing without the fragility

Supplements sit at the intersection of aggressive direct-response marketing, continuity billing, and health claims that regulators watch closely. Years of free-trial and negative-option abuse by bad actors have trained underwriters to treat the entire vertical as guilty until proven otherwise, so even clean straight-sale brands inherit the category's risk premium.

Why processors flag this vertical

The FTC has a long enforcement history against supplement marketers over deceptive free trials, hidden continuity terms, and unsubstantiated health claims, and acquirers price that regulatory exposure into every merchant in the category.
Structure-function claims are governed by DSHEA and policed by both the FDA and FTC, and a single warning letter about disease claims can trigger an acquirer to freeze or terminate a MID.
Trial-to-continuity offers historically produced chargeback ratios well above card-brand monitoring thresholds, so the vertical carries a chargeback reputation that predates any individual merchant.
Many supplement offers run through affiliate networks whose traffic quality the merchant cannot fully control, which introduces misleading pre-sell pages and compliance drift the acquirer ultimately answers for.
Ingredient risk is real: compounds like DMAA, SARMs, or ephedra analogues have been banned or restricted, and acquirers do not want to be processing for a product the FDA later pulls.
Refund and cancellation friction in continuity nutra offers drives complaint volume to the BBB, state attorneys general, and card issuers, all of which feed back into acquirer risk models.

What drives chargebacks here

Customers who accepted a discounted trial dispute the full-price rebill because the continuity terms were buried below the buy button or in the order bump.
Billing descriptors that show a corporate entity or fulfillment name instead of the brand the customer remembers cause instant unrecognized-transaction disputes.
Aggressive advertorial claims set expectations the product cannot meet in thirty days, and disappointed customers dispute rather than request a refund.
Customers who cannot reach support or cancel easily go straight to their issuing bank, converting what should have been a refund into a chargeback.
Multi-bottle upsell funnels create larger single tickets, and higher ticket sizes correlate with more disputes when buyer's remorse sets in.

Processing challenges to expect

Stripe, PayPal, and Square all restrict or prohibit supplement categories they consider high-risk, especially anything with trial or continuity billing, so aggregator accounts get shut down without warning.
High-risk underwriters demand full label copy, certificates of analysis, fulfillment records, and every marketing page including affiliate pre-sells before approving a MID.
Continuity supplement offers are typically coded under high-risk MCCs such as 5968 for direct marketing subscription merchants, which draws card-brand scrutiny and registration requirements.
Rolling reserves of 5 to 10 percent and monthly volume caps are standard on new nutra MIDs, which strains cash flow for brands scaling paid media.
A prior MATCH listing from a failed offer follows the principals, not the entity, and makes every subsequent underwriting application harder.

The infrastructure playbook

Run separate MIDs for straight-sale and continuity offers so a chargeback spike on the subscription side cannot take down your entire processing capacity.
Tokenize your rebill file outside any single processor from day one; nutra continuity revenue is stored-credential revenue, and a PSP termination that takes the vault with it ends the rebills your whole offer economics depend on.
Keep at least one warm backup acquiring relationship underwritten and lightly transacting, since nutra terminations tend to come with little notice and re-underwriting from cold takes weeks.
Enroll every MID in Ethoca Alerts and Verifi RDR or CDRN so you can refund disputes before they post as chargebacks and stay under VAMP thresholds.
Enforce descriptor hygiene: the billing descriptor should show the brand name the customer bought from plus a phone number that reaches a human who can cancel and refund on the first call.
Send a plain-language reminder email before every trial conversion and rebill; it measurably cuts disputes and is required by Visa's rules for trial and subscription merchants anyway.

Frequently asked questions

Can I sell supplements on Stripe or Shopify Payments?: Sometimes, but not safely at scale. Stripe and Shopify Payments both restrict supplement categories they deem high-risk, and enforcement is inconsistent: brands run for months and then get terminated with funds held, often right as ad spend peaks. If you are past roughly $50K per month, move core volume to a dedicated high-risk merchant account and keep the aggregator, if at all, as a small secondary rail.
What chargeback rate will get my supplement MID shut down?: Visa's VAMP program, which replaced the old VDMP and VFMP programs in 2025, and Mastercard's ECM program are the formal thresholds, but your acquirer will act well before the card brands do. In practice most high-risk acquirers start conversations around 0.9 to 1 percent and terminate or reserve heavily beyond that. Continuity nutra offers need alerts and pre-rebill notifications to stay under those lines.
Do I need to change my funnel to get approved?: Usually yes, at least at the margins. Underwriters will reject funnels with disease claims, fake countdown scarcity, undisclosed continuity terms, or checkout pages where the rebill terms are not adjacent to the buy button. Cleaning those up before applying is faster than arguing after a decline, and it also lowers the disputes that would threaten the account later.

Related verticals